AMArmel Evouna Mbarga

Armel Evouna Mbarga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Armel Evouna Mbarga has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mpox Clinical and Epidemiological Patterns in the Central African Republic: a Systematic Review and Meta-analysis

    by Fabrice Zobel Lekeumo Cheuyem, Davy Roméo Takpando- Le-Grand, Chabeja Achangwa, Lionel Berthold Keubou Boukeng, Solange Dabou, Henri Donald Mutarambirwa, Raissa Katy Noa Otsali, Ariane Nouko, Michel Franck Edzamba, Martine Golda Mekouzou Tsafack, et al.

    This study included 40 years evidences (1984-2024) describing the Mpox epidemiology, vaccination and clinical pattern in the Central African Republic (CAR), informing targeted control strategies for this re-emerging threat. This systematic review and meta-analysis followed the PRISMA guidelines. The searches was conducted on PubMed, Scopus, ScienceDirect, Web of science, Embase, Cochrane Library, and AJOL. The random effect model was used to pooled estimates with R version 4.5.2. A p-value <0.05 was considered statistically significant. We included a total of seven studies conducted from 1984 to 2023. Our analysis revealed a pooled severity rate of 60.92% (95% confidence interval (CI): 47.54-72.83), peaking at 77.27% (95%CI: 55.64-90.21) in Health Region 6. Before the global Mpox outbreak in 2022, the case fatality rate (CFR) for confirmed cases was 10.71% (95% CI: 4.52-23.28). Eastern Health Regions had a higher CFR of 10.81% (95% CI: 4.03-25.93), while Western Regions reported 0.00% (95% CI: 0.00-100.00). For suspected cases, the CFR was 12.13% (95% CI: 5.59-24.34), slightly declining to 9.09% (95% CI: 0.23-41.28) post-2022. This geographic disparity remained, with Eastern Regions at 10.17% (95% CI: 4.64-20.84) and Western Regions at 5.26% (95% CI: 0.74-29.39). Vaccination uptake in CAR was 20.00% (95% CI: 10.33-35.17). The clinical profile included fever (91.1% (95%CI: 42.9-99.3)), rash (85.5% (95%CI: 75.7-91.8)), and lymphadenopathy (57.0% (95%CI: 34.3-77.1)). The CAR is one of the most affected countries in Africa by Mpox. This was characterized by high severity, elevated mortality, and suboptimal vaccine coverage, particularly in eastern regions. In order to prevent future outbreak in the country, these findings point the necessity to improve vaccination distribution, give priority to high (risk populations, and improve the surveillance systems with genomic sequencing capacity. In context-specific interventions, including community education on prevention measures and healthcare worker training will help reducing the mpox-related morbidity and mortality.

  • Open Access

    Epidemiological description and analysis of factors associated with cholera morbidity and mortality in Cameroon from 2018 to 2023

    by Akenji Blaise Mboringong, Sen Claudine Ngomtcho, Evouna Armel, Esso Linda, Dibog Luc, Mendjime Patricia, Belinga Sandrine, Balana Flore, Theodore Ntamack, Etoundi Mballa, et al.

    Introduction Cameroon has faced frequent and severe cholera outbreaks since 1971, with high lethality. Previous studies have examined some risk factors and groups, but not for the 2018–2023 period. We analysed the profiles of cholera epidemics and determined factors associated with morbidity and mortality from cholera during this period. Materials and methods We conducted an analytical cross-sectional study using Ministry of Health cholera databases from 2018–2023. We described the socio-demographic, clinical and geographical distribution of cholera cases and used multiple regression to identify factors associated with cholera lethality. Results Between May 2018 and March 2023, there were four cholera epidemics with 18,986 cases, affecting 8/10 regions. The three coastal regions notified 83.4% (15,839/18,986) of cases. The most represented age group were those aged 25–35 years (21.9%; 4,163/1,876) and the M/F sex ratio was 1.27. The overall CFR was 2.7% (478 deaths/17,967 cases) and was highest among persons >65 years (6.8%; 59/869). Urban areas notified more cases than rural areas (13,267 vs 5,484). Factors associated with increased mortality were female sex (aOR 0.62, 95% CI 0.49-0.77), rainy season (aOR 0.60, 95% CI 0.45-0.78) and age below 45 years (aOR 0.56, 95% CI 0.45-0.69). Severe dehydration at consultation (aOR 12.76, 95% CI 7.66-21.25) was associated with higher mortality. Conclusion There were frequent cholera epidemics affecting nearly all administrative regions in Cameroon from 2018 to 2023. Factors associated with decreased mortality from cholera were female sex, living in urban areas, the rainy season, and age less than 45 years. The high caseloads and case fatality rates further reiterate the need for a multisectoral approach to the fight against cholera in Cameroon.